Generic Drugs Head to the Supreme Court

The Supreme Court is set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.

Guests:

• Hans Sauer, adjunct professor, Georgetown Law; former vice president of intellectual property, Biotechnology Innovation Organization
• Sean Tu, professor of law, University of Alabama
• Dennies Varughese, partner; Sterne, Kessler, Goldstein and Fox
• Leslie Walker, senior reporter, Tradeoffs

Learn more and read a full transcript on our website.

Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.

Support this type of journalism today, with a gift.

Hosted on Acast. See acast.com/privacy for more information.